SenzaGen AB Statistics

Total Valuation

SenzaGen AB has a market cap or net worth of SEK 142.21 million. The enterprise value is 104.38 million.

Market Cap	142.21M
Enterprise Value	104.38M

Important Dates

The next estimated earnings date is Wednesday, May 14, 2025.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

SenzaGen AB has 29.50 million shares outstanding. The number of shares has increased by 12.82% in one year.

Current Share Class	n/a
Shares Outstanding	29.50M
Shares Change (YoY)	+12.82%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	26.14%
Owned by Institutions (%)	13.06%
Float	21.79M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.46
PB Ratio	1.64
P/TBV Ratio	3.21
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5.85
EV / Sales	1.81
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-10.45

Financial Position

The company has a current ratio of 2.66, with a Debt / Equity ratio of 0.02.

Current Ratio	2.66
Quick Ratio	2.47
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-0.18
Interest Coverage	-193.13

Financial Efficiency

Return on equity (ROE) is -23.14% and return on invested capital (ROIC) is -8.42%.

Return on Equity (ROE)	-23.14%
Return on Assets (ROA)	-6.35%
Return on Invested Capital (ROIC)	-8.42%
Return on Capital Employed (ROCE)	-12.01%
Revenue Per Employee	1.70M
Profits Per Employee	-525,000
Employee Count	34
Asset Turnover	0.55
Inventory Turnover	3.83

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -24.45% in the last 52 weeks. The beta is 0.32, so SenzaGen AB's price volatility has been lower than the market average.

Beta (5Y)	0.32
52-Week Price Change	-24.45%
50-Day Moving Average	5.28
200-Day Moving Average	6.74
Relative Strength Index (RSI)	46.68
Average Volume (20 Days)	27,216

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SenzaGen AB had revenue of SEK 57.70 million and -17.85 million in losses. Loss per share was -0.65.

Revenue	57.70M
Gross Profit	38.59M
Operating Income	-10.62M
Pretax Income	-18.36M
Net Income	-17.85M
EBITDA	-1.80M
EBIT	-10.62M
Loss Per Share	-0.65

Full Income Statement

Balance Sheet

The company has 39.61 million in cash and 1.78 million in debt, giving a net cash position of 37.83 million or 1.28 per share.

Cash & Cash Equivalents	39.61M
Total Debt	1.78M
Net Cash	37.83M
Net Cash Per Share	1.28
Equity (Book Value)	86.64M
Book Value Per Share	2.94
Working Capital	38.92M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -9.33 million and capital expenditures -656,000, giving a free cash flow of -9.99 million.

Operating Cash Flow	-9.33M
Capital Expenditures	-656,000
Free Cash Flow	-9.99M
FCF Per Share	-0.34

Full Cash Flow Statement

Margins

Gross margin is 66.89%, with operating and profit margins of -18.41% and -30.94%.

Gross Margin	66.89%
Operating Margin	-18.41%
Pretax Margin	-31.82%
Profit Margin	-30.94%
EBITDA Margin	-3.12%
EBIT Margin	-18.41%
FCF Margin	n/a

Dividends & Yields

SenzaGen AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.82%
Shareholder Yield	-12.82%
Earnings Yield	-12.55%
FCF Yield	-7.02%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SenzaGen AB has an Altman Z-Score of 5.81.

Altman Z-Score	5.81
Piotroski F-Score	n/a